James T Forbes
Overview
Explore the profile of James T Forbes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Severson J, Hagen C, Tack J, Maestas J, Naugle D, Forbes J, et al.
PLoS One
. 2017 Mar;
12(3):e0174347.
PMID: 28333995
Sagebrush (Artemisia spp.) obligate wildlife species such as the imperiled greater sage-grouse (Centrocercus urophasianus) face numerous threats including altered ecosystem processes that have led to conifer expansion into shrub-steppe. Conifer...
2.
Miller T, Forbes J, Shah C, Wyatt S, Manning H, Olivares M, et al.
Clin Cancer Res
. 2009 Nov;
15(23):7266-76.
PMID: 19934303
Purpose: A significant fraction of HER2-overexpressing breast cancers exhibit resistance to the HER2 antibody trastuzumab. Hyperactivity of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway confers trastuzumab resistance, and mammalian target of rapamycin...
3.
Reyzer M, Caldwell R, Dugger T, Forbes J, Ritter C, Guix M, et al.
Cancer Res
. 2004 Dec;
64(24):9093-100.
PMID: 15604278
Biomarkers that predict therapeutic response are essential for the development of anticancer therapies. We have used matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) to directly analyze protein profiles in mouse mammary...
4.
Muraoka-Cook R, Kurokawa H, Koh Y, Forbes J, Roebuck L, Barcellos-Hoff M, et al.
Cancer Res
. 2004 Dec;
64(24):9002-11.
PMID: 15604265
To address the role of transforming growth factor (TGF) beta in the progression of established tumors while avoiding the confounding inhibitory effects of TGF-beta on early transformation, we generated doxycycline...